Electrocardiology of atrial fibrillation: Current knowledge and future challenges

IEEE Engineering in Medicine and Biology Magazine

Volumn 25, Issue 6, 2006, Pages 15-23

  Bollmann, Andreas ^a,b,c,d,e   Lombardi, Federico ^f  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^c EMORY UNIVERSITY   (United States)

^d LUND UNIVERSITY   (Sweden)

^e HARBOR UCLA MEDICAL CENTER   (United States)

^f UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BEPRIDIL; DISOPYRAMIDE; FLECAINIDE; IBUTILIDE; PILSICAINIDE;

CARDIOLOGY; CLINICAL PRACTICE; ELECTROCARDIOGRAM; HEART ATRIUM FIBRILLATION; HEART RIGHT ATRIUM; HEART SURGERY; HUMAN; PATHOPHYSIOLOGY; PRINCIPAL COMPONENT ANALYSIS; QUALITY OF LIFE; REVIEW; SINUS RHYTHM; WOLFF PARKINSON WHITE SYNDROME;

ATRIAL FIBRILLATION; CATHETER ABLATION; ELECTRIC COUNTERSHOCK; HUMANS;

EID: 33845866645     PISSN: 07395175     EISSN: None     Source Type: Journal    
DOI: 10.1109/EMB-M.2006.250504     Document Type: Review

References (68)

1. V. Fuster, L.E. Ryden, R.W. Asinger, D.S. Cannom, H.J. Crijns, R.L. Frye, J.L. Halperin, G.N. Kay, W.W. Klein, S. Levy, R.L. McNamara, E.N. Prystowsky, L.S. Wann, D.G. Wyse, R.J. Gibbons, E.M. Antman, J.S. Alpert, D.P. Faxon, G. Gregoratos, L.F. Hiratzka, A.K. Jacobs, R.O. Russell, S.C. Smith, Jr., A. Alonso-Garcia, C. Blomstrom-Lundqvist, G. de Backer, M. Flather, J. Hradec, A. Oto, A. Parkhomenko, S. Silber, and A. Torbicki, "ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: Executive summary a report of the American college of cardiology/american heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines and policy conferences (committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the north american society of pacing and electrophysiology, " Circulation, vol. 104, pp. 2118-2150, 2001.
2. S. Stewart, N. Murphy, A. Walker, A. McGuire, and J.J.V. McMurray, "Cost of an emerging epidemic: An economic analysis of atrial fibrillation in the UK," Heart, vol. 90, pp. 286-292, 2004.
3. D.G. Wyse, A.L. Waldo, J.P. DiMarco, M.J. Domanski, Y. Rosenberg, E.B. Schron, J.C. Kellen, H.L. Greene, M.C. Mickel, J.E. Dalquist, and S.D. Corley, "A comparison of rate control and rhythm control in patients with atrial fibrillation," New Eng. J. Med., vol. 347, pp. 1825-1833, 2002.
4. I.C. Van Gelder, V.E. Hagens, H.A. Bosker, J.H. Kingma, O. Kamp, T. Kingma, S.A. Said, J.I. Darmanata, A.J. Timmermans, J.G. Tijssen, and H.J. Crijns, "A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation," New Eng. J. Med., vol. 347, pp. 1834-1840, 2002.
5. A. Bollmann, "First comes diagnosis then comes treatment: An underappreciated paradigm in atrial fibrillation management," Eur. Heart J., to be published.
6. M.C. Wijffels, C.J. Kirchhof, R. Dorland, and M.A. Allessie, "Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats," Circulation, vol. 92, pp. 1954-1968, 1995.
7. J.L. Wells, Jr., R.B. Karp, N.T. Kouchoukos, W.A. MacLean, T.N. James, and A.L. Waldo, "Characterization of atrial fibrillation in man: Studies following open heart surgery," Pacing Clin. Electrophysiol., vol. 1, pp. 426-438, 1978.
8. H. Li, J. Hare, K. Mughal, D. Krum, M. Biehl, S. Deshpande, A. Dhala, Z. Blanck, J. Sra, M. Jazayeri, and M. Akhtar, "Distribution of atrial electrogram types during atrial fibrillation: Effect of rapid atrial pacing and intercaval junction ablation," J. Amer. Coll. Cardiol., vol. 27, pp. 1713-1721, 1996.
9. K.T. Konings, C.J. Kirchhof, J.R. Smeets, H.J. Wellens, O.C. Penn, and M.A. Allessie, "High-density mapping of electrically induced atrial fibrillation in humans," Circulation, vol. 89, pp. 1665-1680, 1994.
10. M. Holm, R. Johansson, J. Brandt, C. Luhrs, and S.B. Olsson, "Epicardial right atrial free wall mapping in chronic atrial fibrillation. Documentation of repetitive activation with a focal spread-a hitherto unrecognised phenomenon in man," Eur. Heart J., vol. 18, pp. 290-310, 1997.
11. M.M. Gallagher and J. Camm, "Classification of atrial fibrillation," Amer. J. Cardiol., vol. 82, pp. 18N-28N, 1998.
12. G.W. Botteron and J.M. Smith, "Quantitative assessment of the spatial organization of atrial fibrillation in the intact human heart," Circulation, vol. 93, pp. 513-518, 1996.
13. K.M. Ropella, A.V. Sahakian, J.M. Baerman, and S. Swiryn, "The coherence spectrum. A quantitative discriminator of fibrillatory and nonfibrillatory cardiac rhythms," Circulation, vol. 80, pp. 112-119, 1989.
14. H.J. Sih, D.P. Zipes, E.J. Berbari, and J.E. Olgin, "A high-temporal resolution algorithm for quantifying organization during atrial fibrillation," IEEE Trans. Biomed. Eng., vol. 46, pp. 440-450, 1999.
15. L.T. Mainardi, V.D. Corino, L. Lombardi, C. Tondo, M. Mantica, F. Lombardi, and S. Cerutti, "Assessment of the dynamics of atrial signals and local atrial period series during atrial fibrillation: Effects of isoproterenol administration," Biomed. Eng. Online, vol. 3, p. 37, 2004.
16. A. Capucci, M. Biffi, G. Boriani, F. Ravelli, G. Nollo, P. Sabbatani, C. Orsi, and B. Magnani, "Dynamic electrophysiological behavior of human atria during paroxysmal atrial fibrillation," Circulation, vol. 92, pp. 1193-1202, 1995.
17. Y. Asano, J. Saito, K. Matsumoto, K. Kaneko, T. Yamamoto, and M. Uchida, "On the mechanism of termination and perpetuation of atrial fibrillation," Amer. J. Cardiol., vol. 69, pp. 1033-1038, 1992.
18. B.S. Stambler, M.A. Wood, and K.A. Ellenbogen, "Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: Electrophysiological determinants of enhanced conversion efficacy," Circulation, vol. 96, pp. 4298-4306, 1997.
19. T.J. Wu, R.N. Doshi, H.L. Huang, C. Blanche, R.M. Kass, A. Trento, W. Cheng, H.S. Karagueuzian, C.T. Peter, and P.S. Chen, "Simultaneous biatrial computerized mapping during permanent atrial fibrillation in patients with organic heart disease," J. Cardiovasc. Electrophysiol., vol. 13, pp. 571-577, 2002.
20. S. Lazar, S. Dixit, F.E. Marchlinski, D.J. Callans, and E.P. Gerstenfeld, "Presence of left-to-right atrial frequency gradient in paroxysmal but not persistent atrial fibrillation in humans," Circulation, vol. 110, pp. 3181-3186, 2004.
21. H. Oral, B.P. Knight, H. Tada, M. Ozaydin, A. Chugh, S. Hassan, C. Scharf, S.W. Lai, R. Greenstein, F. Pelosi, Jr., S.A. Strickberger, and F. Morady, "Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation," Circulation, vol. 105, pp. 1077-1081, 2002.
22. K. Nademanee, J. McKenzie, E. Kosar, M. Schwab, B. Sunsaneewitayakul, T. Vasavakul, C. Khunnawat, and T. Ngarmukos, "A new approach for catheter ablation of atrial fibrillation: Mapping of the electrophysiologic substrate," J. Amer. Coll. Cardiol., vol. 43, pp. 2044-2053, 2004.
23. K.T. Konings, J.L. Smeets, O.C. Penn, H.J. Wellens, and M.A. Allessie, "Configuration of unipolar atrial electrograms during electrically induced atrial fibrillation in humans," Circulation, vol. 95, pp. 1231-1241, 1997.
24. W. Einthoven, "Le Télécardiogramme," Arch. Int. Physiol, vol. 4, pp. 132-164, 1906.
25. D. Husser, M. Stridh, L. Sornmo, P. Platonov, S.B. Olsson, and A. Bollmann, "Analysis of the surface electrocardiogram for monitoring and predicting antiarrhythmic drug effects in atrial fibrillation," Cardiovasc. Drugs Ther., vol. 18, pp. 377-386, 2004.
26. P. Zimetbaum, K.K. Ho, B. Olshansky, T. Hadjis, R. Lemery, P.A. Friedman, D.S. Cannom, X.H. Chen, and M.E. Josephson, "Variation in the utilization of antiarrhythmic drugs in patients with new-onset atrial fibrillation," Amer. J. Cardiol., vol. 91, pp. 81-83, 2003.
27. A. Plewan, G. Lehmann, G. Ndrepepa, J. Schreieck, E.U. Alt, A. Schomig, and C. Schmitt, "Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation: sotalol versus bisoprolol," Eur. Heart J., vol. 22, pp. 1504-1510, 2001.
28. D. Roy, M. Talajic, P. Dorian, S. Connolly, M.J. Eisenberg, M. Green, T. Kus, J. Lambert, M. Dubuc, P. Gagne, S. Nattel, and B. Thibault, "Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators," N. Eng. J. Med., vol. 342, pp. 913-920, 2000.
29. AFFIRM First Antiarrhythmic Drug Substudy Investigators, "Maintenance of sinus rhythm in patients with atrial fibrillation: An AFFIRM substudy of the first antiarrhythmic drug," J. Amer. Coll. Cardiol., vol. 42, pp. 20-29, 2003.
30. A. Bollmann, D. Husser, M. Stridh, L. Soernmo, M. Majic, H.U. Klein, and S.B. Olsson, "Frequency measures obtained from the surface electrocardiogram in atrial fibrillation research and clinical decision-making," J. Cardiovasc. Electrophysiol., vol. 14, pp. S154-S161, 2003.
31. M. Stridh and L. Sornmo, "Spatiotemporal QRST cancellation techniques for analysis of atrial fibrillation," IEEE Trans. Biomed. Eng., vol. 48, pp. 105-111, 2001.
32. P. Langley, M. Stridh, J.J. Rieta, J. Millet Roig, L. Sörnmo, and A. Murray, "Comparison of three atrial rhythm extraction techniques for the detection of the main atrial frequency from the 12-lead ECG in atrial fibrillation," IEEE Trans. Biomed. Eng., to be published.
33. M. Holm, S. Pehrson, M. Ingemansson, L. Sornmo, R. Jahansson, L. Sandhall, M. Sunemark, B. Smideberg, C. Olsson, and S.B. Olsson, "Non-invasive assessment of the atrial cycle length during atrial fibrillation in man: Introducing, validating and illustrating a new ECG method," Cardiovasc. Res., vol. 38, pp. 69-81, 1998.
34. A. Bollmann, N.K. Kanuru, K.K. McTeague, P.F. Walter, D.B. DeLurgio, and J.J. Langberg, "Frequency analysis of human atrial fibrillation using the surface electrocardiogram and its response to ibutilide," Amer. J. Cardiol., vol. 81, pp. 1439-1445, 1998.
35. A. Bollmann, K.H. Binias, I. Toepffer, J. Molling, C. Geller, and H.U. Klein, "Importance of left atrial diameter and atrial fibrillatory frequency for conversion of persistent atrial fibrillation with oral flecainide," Amer. J. Cardiol., vol. 90, pp. 1011-1014, 2002.
36. A. Fujiki, T. Tsuneda, M. Sugao, K. Mizumaki, and H. Inoue, "Usefulness and safety of bepridil in converting persistent atrial fibrillation to sinus rhythm," Amer. J. Cardiol., vol. 92, pp. 472-475, 2003.
37. R.A. Schwartz and J.J. Langberg, "Atrial electrophysiological effects of ibutilide infusion in humans," Pacing Clin. Electrophysiol., vol. 23, pp. 832-836, 2000.
38. A. Bollmann, M. Mende, A. Neugebauer, and D. Pfeiffer, "Atrial fibrillatory frequency predicts atrial defibrillation threshold and early arrhythmia recurrence in patients undergoing internal cardioversion of persistent atrial fibrillation," Pacing Clin. Electrophysiol., vol. 25, pp. 1179-1184, 2002.
39. J.J. Langberg, J.C. Burnette, and K.K. McTeague, "Spectral analysis of the electrocardiogram predicts recurrence of atrial fibrillation after cardioversion," J. Electrocardiol., vol. 31 Suppl., pp. 80-84, 1998.
40. A. Bollmann, D. Husser, R. Steinert, M. Stridh, L. Soernmo, S.B. Olsson, D. Polywka, J. Molling, C. Geller, and H.U. Klein, "Echo- and electrocardiographic predictors for atrial fibrillation recurrence following cardioversion," J. Cardiovasc. Electrophysiol., vol. 14, pp. S162-S165, 2003.
41. M. Stridh, L. Sornmo, C.J. Meurling, and S.B. Olsson, "Characterization of atrial fibrillation using the surface ECG: Time-dependent spectral properties," IEEE Trans. Biomed. Eng., vol. 48, pp. 19-27, 2001.
42. D. Husser, M. Stridh, L. Sornmo, C. Geller, H.U. Klein, S.B. Olsson, and A. Bollmann, "Time-frequency analysis of the surface electrocardiogram for monitoring antiarrhythmic drug effects in atrial fibrillation," Amer. J. Cardiol., vol. 95, pp. 526-528, 2005.
43. I. Kubara, H. Ikeda, T. Hiraki, T. Yoshida, M. Ohga, and T. Imaizumi, "Dispersion of filtered P wave duration by P wave signal-averaged ECG mapping system: Its usefulness for determining efficacy of disopyramide on paroxysmal atrial fibrillation," J. Cardiovasc. Electrophysiol., vol. 10, pp. 670-679, 1999.
44. T. Yamada, M. Fukunami, T. Shimonagata, K. Kumagai, S. Sanada, H. Ogita, Y. Asano, M. Hori, and N. Hoki, "Dispersion of signal-averaged P wave duration on precordial body surface in patients with paroxysmal atrial fibrillation," Eur. Heart J., vol. 20, pp. 211-220, 1999.
45. P.J. Stafford, J. Cooper, D.P. de Bono, R. Vincent, and C.J. Garratt, "Effect of low dose sotalol on the signal averaged P wave in patients with paroxysmal atrial fibrillation," Br. Heart J., vol. 74, pp. 636-640, 1995.
46. W. Banasiak, A. Telichowski, S.D. Anker, A. Fuglewicz, D. Kalka, W. Molenda, K. Reczuch, J. Adamus, A.J. Coats, and P. Ponikowski, "Effects of amiodarone on the P-wave triggered signal-averaged electrocardiogram in patients with paroxysmal atrial fibrillation and coronary artery disease," Amer. J. Cardiol., vol. 83, pp. 112-114, A9, 1999.
47. G. Opolski, P. Scislo, J. Stanislawska, A. Gorecki, R. Steckiewicz, and A. Torbicki, "Detection of patients at risk for recurrence of atrial fibrillation after successful electrical cardioversion by signal-averaged P-wave ECG," Int. J. Cardiol., vol. 60, pp. 181-185, 1997.
48. K. Aytemir, S. Aksoyek, A. Yildirir, N. Ozer, and A. Oto, "Prediction of atrial fibrillation recurrence after cardioversion by P wave signal-averaged electrocardiography," Int. J. Cardiol., vol. 70, pp. 15-21, 1999.
49. M.H. Raitt, K.D. Ingram, and S.M. Thurman, "Signal-averaged P wave duration predicts early recurrence of atrial fibrillation after cardioversion," Pacing Clin. Electrophysiol., vol. 23, pp. 259-265, 2000
50. M. Budeus, M. Hennersdorf, C. Perings, and B.E. Strauer, "The prediction of atrial fibrillation recurrence after electrical cardioversion with P wave signal averaged EKG," Z Kardiol., vol. 93, pp. 474-478, 2004.
51. U. Dixen, C. Joens, J. Parner, V. Rasmussen, S.M. Pehrson, and G.B. Jensen, "Prolonged signal-averaged P wave duration after elective cardioversion increases the risk of recurrent atrial fibrillation," Scand. Cardiovasc. J., vol. 38, pp. 147-151, 2004.
52. Y. Abe, M. Fukunami, T. Yamada, M. Ohmori, T. Shimonagata, K. Kumagai, J. Kim, S. Sanada, M. Hori, and N. Hoki, "Prediction of transition to chronic atrial fibrillation in patients with paroxysmal atrial fibrillation by signal-averaged electrocardiography: A prospective study," Circulation, vol. 96, pp. 2612-2616, 1997.
53. P.E. Dilaveris, E.J. Gialafos, G.K. Andrikopoulos, D.J. Richter, V. Papanikolaou, K. Poralis, and J.E. Gialafos, "Clinical and electrocardiographic predictors of recurrent atrial fibrillation," Pacing Clin. Electrophysiol., vol. 23, pp. 352-358, 2000.
54. M.P. Ingemansson, J. Carlson, P. Platonov, and S.B. Olsson, "Effects of MgSO4 and glucose, insulin and potassium (GIK) on atrial conduction during the first 12 hours after dc-conversion of chronic atrial fibrillation," Scan. Cardiovasc. J., vol. 35, pp. 340-346, 2001.
55. P.G. Platonov, J. Carlson, M.P. Ingemansson, A. Roijer, A. Hansson, L.V. Chireikin, and S.B. Olsson, "Detection of inter-atrial conduction defects with unfiltered signal-averaged P-wave ECG in patients with lone atrial fibrillation," Europace, vol. 2, pp. 32-41, 2000.
56. B. Herweg, P. Dalal, B. Nagy, and P. Schweitzer, "Power spectral analysis of heart period variability of preceding sinus rhythm before initiation of paroxysmal atrial fibrillation," Amer. J. Cardiol., vol. 82, pp. 869-874, 1998.
57. Z.C. Wen, S.A. Chen, C.T. Tai, J.L. Huang, and M.S. Chang, "Role of autonomic tone in facilitating spontaneous onset of typical atrial flutter," J. Amer. Coll. Cardiol., vol. 31, pp. 602-607, 1998.
58. M. Bettoni and M. Zimmermann, "Autonomic tone variations before the onset of paroxysmal atrial fibrillation," Circulation, vol. 105, pp. 2753-2759, 2002.
59. F. Lombardi, D. Tarricone, F. Tundo, F. Colombo, S. Belletti, and C. Fiorentini, "Autonomic nervous system and paroxysmal atrial fibrillation: A study based on the analysis of RR interval changes before, during and after paroxysmal atrial fibrillation," Eur. Heart J., vol. 25, pp. 1242-1248, 2004.
60. F. Lombardi, A. Colombo, B. Basilico, R. Ravaglia, M. Garbin, D. Vergani, P.M. Battezzati, and C. Fiorentini, "Heart rate variability and early recurrence of atrial fibrillation after electrical cardioversion," J. Amer. Coll. Cardiol., vol. 37, pp. 157-162, 2001.
61. E.M. Kanoupakis, E.G. Manios, H.E. Mavrakis, M.D. Kaleboubas, F.I. Parthenakis, and P.E. Vardas, "Relation of autonomic modulation to recurrence of atrial fibrillation following cardioversion," Amer. J. Cardiol., vol. 86, pp. 954-958, 2000.
62. S. Vikman, K. Lindgren, T.H. Makikallio, S. Yli-Mayry, K.E. Airaksinen, and H.V. Huikuri, "Heart rate turbulence after atrial premature beats before spontaneous onset of atrial fibrillation," J. Amer. Coll. Cardiol., vol. 45, pp. 278-284, 2005.
63. J. Billette, R.A. Nadeau, and F. Roberge, "Relation between the minimum RR interval during atrial fibrillation and the functional refractory period of the AV junction," Cardiovasc. Res., vol. 8, pp. 347-351, 1974.
64. M.P. Van den Berg, T. Van Noord, J. Brouwer, J. Haaksma, D.J. Van Veldhuisen, H.J. Crijns, and I.C. Van Gelder, "Clustering of RR intervals predicts effective electrical cardioversion for atrial fibrillation," J. Cardiovasc. Electrophysiol., vol. 15, pp. 1027-1033, 2004.
65. S.B. Olsson, N. Cai, M. Dohnal, and K.K. Talwar, "Noninvasive support for and characterization of multiple intranodal pathways in patients with mitral valve disease and atrial fibrillation," Eur. Heart J., vol. 7, pp. 320-333, 1986.
66. S. Rokas, S. Gaitanidou, S. Chatzidou, N. Agrios, and S. Stamatelopoulos, "A noninvasive method for the detection of dual atrioventricular node physiology in chronic atrial fibrillation," Amer. J. Cardiol., vol. 84, pp. 1442-1445, A8, 1999.
67. S. Rokas, S. Gaitanidou, S. Chatzidou, C. Pamboucas, D. Achtipis, and S. Stamatelopoulos, "Atrioventricular node modification in patients with chronic atrial fibrillation: Role of morphology of RR interval variation," Circulation, vol. 103, pp. 2942-2948, 2001.
68. J. Tebbenjohanns, B. Schumacher, T. Korte, M. Niehaus, and D. Pfeiffer, "Bimodal RR interval distribution in chronic atrial fibrillation: Impact of dual atrioventricular nodal physiology on long-term rate control after catheter ablation of the posterior atrionodal input," J. Cardiovasc. Electrophysiol., vol. 11, pp. 497-503, 2000.